OxyContin News and Research

RSS

Millennium Laboratories announces new clinical quantitative assay and drug screening tests for healthcare

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain patients, announced today the company’s development and validation of a clinical quantitative assay for the new drug tapentadol (Nucynta™) by liquid chromatography/tandem mass spectrometry (LC-MS/MS).

12 Nov 2009

Eleven accused of scamming Medicare in Michigan

Eleven people were charged in an indictment unsealed on Thursday with "scamming Medicare to get painkillers," the Associated Press reports.

5 Jun 2009

Oxycodone effective against shingles pain

The painkiller oxycodone is effective at treating the acute pain of shingles, an illness that often causes severe pain which can become long-lasting and sometimes even permanent.

26 Mar 2009

Decline in teen marijuana use stalls - trends in cigarette and alcohol use continues to fall

There are signs that the ongoing decline in teen marijuana use in recent years has stalled; however the downward trend in cigarette and alcohol use continues, according to the 2008 Monitoring the Future (MTF) Survey. Results were announced today at a news conference.

11 Dec 2008

TheraQuest's IND for abuse deterrent strong opioid (TQ-1015) accepted by FDA

TheraQuest Biosciences, Inc. a development stage pain management company today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug ("IND") application for TQ-1015, its abuse deterrent extended release strong opioid. TQ-1015 is being developed using Securel, TheraQuest's proprietary abuse deterrent technology.

13 Nov 2008

Extended suboxone treatment substantially improves outcomes for opioid-addicted young adults

In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.

4 Nov 2008

Abuse of painkillers can predispose adolescents to lifelong addiction

No child aspires to a lifetime of addiction. But their brains might. In new research to appear online in the journal Neuropsychopharmacology today, Rockefeller University researchers reveal that adolescent brains exposed to the painkiller OxyContin can sustain lifelong and permanent changes in their reward system - changes that increase the drug's euphoric properties and make such adolescents more vulnerable to the drug's effects later in adulthood.

10 Sep 2008

OxyContin drug company sued for millions

A private company in the United States is being sued by a number of counties in the state of Kentucky over the potent painkilling drug OxyContin.

7 Oct 2007

Research explains why opioids are thought to be ineffective in people with fibromyalgia

People who have the common chronic pain condition fibromyalgia often report that they don't respond to the types of medication that relieve other people's pain.

27 Sep 2007

Americans popping more pills

Americans are it seems popping more pills than ever, as according to an analysis of federal data, sales of leading painkiller medications soared by 90 percent in the eight years between 1997 and 2005.

21 Aug 2007

National study to treat addiction to prescription pain medications

Researchers funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, launched the first large-scale national study evaluating a treatment for addiction to prescription opioid analgesics (i.e., painkillers) such as Vicodin and OxyContin.

10 Jul 2007

Abuse of prescription drugs

Increasingly, drug abusers are getting their next fix from their medicine cabinets, instead of from drug dealers.

26 Jun 2007

AMPAKINE drugs may provide protection from drug-induced respiratory depression

Drug-induced respiratory depression is a life-threatening condition caused by analgesic, hypnotic, and anesthesia medications.

5 Jun 2007

FDA announces results of investigation into illegal promotion of OxyContin

The U.S. Food and Drug Administration's (FDA) Office of Criminal Investigations (OCI) has announced that The Purdue Frederick Company, Inc. has agreed to pay more than $700 million to resolve criminal charges and civil liabilities in connection with several illegal schemes to promote, market and sell OxyContin, a powerful prescription pain reliever that the company produces.

11 May 2007

First large-scale study to assess treatment for prescription drug addiction

UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.

19 Apr 2007

Warning about the indiscriminate use of diet drugs

The United Nations (UN) has issued a warning about the rise in a number of countries of the use of diet drugs to lose weight.

1 Mar 2007

Lawsuit filed against federal government over medical cannabis misinformation

The patients advocacy group Americans for Safe Access (ASA) filed a lawsuit in the United States District Court for the Northern District of California demanding that the federal government cease issuing misinformation on medical cannabis and correct the information it has released.

21 Feb 2007